|
1
|
Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats.
|
J Endocrinol
|
2008
|
1.10
|
|
2
|
Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein.
|
Psychopharmacology (Berl)
|
2006
|
0.95
|
|
3
|
Population pharmacokinetic analysis of drug-drug interactions among risperidone, bupropion, and sertraline in CF1 mice.
|
Psychopharmacology (Berl)
|
2005
|
0.91
|
|
4
|
Aripiprazole brain concentration is altered in P-glycoprotein deficient mice.
|
Schizophr Res
|
2009
|
0.83
|
|
5
|
Prediction and in vitro evaluation of selected protease inhibitor antiviral drugs as inhibitors of carboxylesterase 1: a potential source of drug-drug interactions.
|
Pharm Res
|
2011
|
0.83
|
|
6
|
The influence of the CYP2C19*10 allele on clopidogrel activation and CYP2C19*2 genotyping.
|
Pharmacogenet Genomics
|
2014
|
0.83
|
|
7
|
Sertraline and its metabolite desmethylsertraline, but not bupropion or its three major metabolites, have high affinity for P-glycoprotein.
|
Biol Pharm Bull
|
2008
|
0.82
|
|
8
|
A sensitive LC-MS/MS assay for the simultaneous analysis of the major active components of silymarin in human plasma.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2012
|
0.82
|
|
9
|
Pharmacokinetics of olanzapine after single-dose oral administration of standard tablet versus normal and sublingual administration of an orally disintegrating tablet in normal volunteers.
|
J Clin Pharmacol
|
2006
|
0.82
|
|
10
|
Antipsychotic drugs inhibit the function of breast cancer resistance protein.
|
Basic Clin Pharmacol Toxicol
|
2008
|
0.81
|
|
11
|
Limitations of in vitro assessments of the drug interaction potential of botanical supplements.
|
Planta Med
|
2012
|
0.81
|
|
12
|
Enantiospecific gas chromatographic-mass spectrometric analysis of urinary methylphenidate: implications for phenotyping.
|
J Chromatogr B Analyt Technol Biomed Life Sci
|
2007
|
0.81
|
|
13
|
Isopropylphenidate: an ester homolog of methylphenidate with sustained and selective dopaminergic activity and reduced drug interaction liability.
|
J Child Adolesc Psychopharmacol
|
2013
|
0.78
|
|
14
|
Regulatory effects of genomic translocations at the human carboxylesterase-1 (CES1) gene locus.
|
Pharmacogenet Genomics
|
2016
|
0.77
|
|
15
|
The psychostimulant d-threo-(R,R)-methylphenidate binds as an agonist to the 5HT(1A) receptor.
|
Pharmazie
|
2009
|
0.77
|
|
16
|
An in vitro evaluation of guanfacine as a substrate for P-glycoprotein.
|
Neuropsychiatr Dis Treat
|
2011
|
0.76
|
|
17
|
Carboxylesterase 1-mediated drug-drug interactions between clopidogrel and simvastatin.
|
Biol Pharm Bull
|
2015
|
0.76
|
|
18
|
A liquid chromatography/tandem mass spectrometry assay for the analysis of atomoxetine in human plasma and in vitro cellular samples.
|
Biomed Chromatogr
|
2012
|
0.75
|
|
19
|
Carboxylesterase 1 (CES1) genetic polymorphisms and oseltamivir activation.
|
Eur J Clin Pharmacol
|
2012
|
0.75
|